JAGX - Jaguar Health, Inc.

10.91
-0.830   -7.608%

Share volume: 86,327
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations: -0.13%

PREVIOUS CLOSE
CHG
CHG%
$11.74
-0.83
-0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2023 06-30-2023 09-30-2023 12-31-2023 03-31-2024 06-30-2024 09-30-2024
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024
Report Date 05-15-2023 08-14-2023 11-14-2023 04-01-2024 05-14-2024 08-13-2024 11-13-2024
Total revenue 1.972 M 2.676 M 2.813 M 2.300 M 2.351 M 2.721 M 3.108 M
Cost of revenue 345.000 K 491.000 K 514.000 K 687.000 K 430.000 K 427.000 K 541.000 K
Gross profit 1.627 M 2.185 M 2.299 M 1.613 M 1.921 M 2.294 M 2.567 M
    34.30% 5.22% -29.84% 19.09% 19.42% 11.90%  
Operating expenses 11.472 M 10.287 M 11.086 M 8.799 M 8.693 M 7.967 M 7.819 M
Selling general and admin 6.697 M 6.010 M 5.005 M 5.336 M 4.381 M 4.314 M 3.776 M
Research and development 4.775 M 4.277 M 6.081 M 3.463 M 4.312 M 3.653 M 4.043 M
Total expenses 11.817 M 10.778 M 11.600 M 9.486 M 10.136 M 9.491 M 9.829 M
    -8.79% 7.63% -18.22% 6.85% -6.36% 3.56%  
Operating income -9.845 M -8.102 M -8.787 M -7.186 M -8.215 M -7.197 M -7.262 M
Ebit -9.845 M -8.102 M -8.787 M -7.186 M -10.002 M -9.736 M -10.183 M
Pretax income -12.397 M -12.291 M -7.904 M -9.309 M -9.368 M -9.628 M -10.021 M
    -0.86% -35.69% 17.78% 0.63% 2.78% 4.08%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -12.202 M -12.150 M -7.778 M -9.170 M 0.000 0.000 0.000
    0.43% 35.98% -17.90% 100.00%      
Net income -12.202 M -12.150 M -7.778 M -9.170 M -9.368 M -9.628 M -10.021 M
    0.43% 35.98% -17.90% -2.16% -2.78% -4.08%